{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:30:53Z","timestamp":1787632253169,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Province Cancer Hospital Talent Development Program","award":["2022YNG02"],"award-info":[{"award-number":["2022YNG02"]}]},{"name":"the Fujian Province Joint Funds for the Innovation of Science and Technology","award":["2023Y9427\uff0c2023Y9409"],"award-info":[{"award-number":["2023Y9427\uff0c2023Y9409"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13665-4","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:56:10Z","timestamp":1738947370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The prognostic value of\u00a0boost dose in residual cervical lymph nodes in\u00a0nasopharyngeal carcinoma patients after\u00a0intensity-modulated radiotherapy: a\u00a0retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Mengting","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaodong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"10192","key":"13665_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)30956-0. (Epub 2019 Jun 6 PMID: 31178151).","journal-title":"Lancet"},{"issue":"10","key":"13665_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13014-015-0401-0.PMID:25881159;PMCID:PMC4464998","volume":"15","author":"Y He","year":"2015","unstructured":"He Y, Zhou Q, Shen L, Zhao Y, Lei M, Wei R, Shen L, Cao S. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma. Radiat Oncol. 2015;15(10):89. https:\/\/doi.org\/10.1186\/s13014-015-0401-0.PMID:25881159;PMCID:PMC4464998.","journal-title":"Radiat Oncol"},{"issue":"5","key":"13665_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7150\/jca.17957.PMID:28382149;PMCID:PMC5381175","volume":"8","author":"JW Lv","year":"2017","unstructured":"Lv JW, Zhou GQ, Li JX, Tang LL, Mao YP, Lin AH, Ma J, Sun Y. Magnetic resonance imaging-detected tumor residue after intensity-modulated radiation therapy and its association with post-radiation plasma epstein-barr virus deoxyribonucleic acid in nasopharyngeal carcinoma. J Cancer. 2017;8(5):861\u20139. https:\/\/doi.org\/10.7150\/jca.17957.PMID:28382149;PMCID:PMC5381175.","journal-title":"J Cancer"},{"key":"13665_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.radonc.2018.10.010","volume":"132","author":"SB Liang","year":"2019","unstructured":"Liang SB, Zhang N, Chen DM, Yang XL, Chen BH, Zhao H, Lu RL, Chen Y, Fu LW. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma. Radiother Oncol. 2019;132:223\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2018.10.010. (Epub 2018 Oct 23 PMID: 30366725).","journal-title":"Radiother Oncol"},{"issue":"6","key":"13665_CR5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/cncr.20099","volume":"100","author":"JY Shao","year":"2004","unstructured":"Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A\/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer. 2004;100(6):1162\u201370. https:\/\/doi.org\/10.1002\/cncr.20099. (PMID: 15022282).","journal-title":"Cancer"},{"issue":"4","key":"13665_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/jjco\/hyq242","volume":"41","author":"C Chen","year":"2011","unstructured":"Chen C, Fei Z, Pan J, Bai P, Chen L. Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol. 2011;41(4):537\u201342. https:\/\/doi.org\/10.1093\/jjco\/hyq242. (Epub 2011 Jan 17 PMID: 21242183).","journal-title":"Jpn J Clin Oncol"},{"key":"13665_CR7","doi-asserted-by":"publisher","unstructured":"Tang LL, Chen YP, Chen CB, Chen MY, Chen NY, Chen XZ, Du XJ, Fang WF, Feng M, Gao J, Han F, He X, Hu CS, Hu DS, Hu GY, Jiang H, Jiang W, Jin F, Lang JY, Li JG, Lin SJ, Liu X, Liu QF, Ma L, Mai HQ, Qin JY, Shen LF, Sun Y, Wang PG, Wang RS, Wang RZ, Wang XS, Wang Y, Wu H, Xia YF, Xiao SW, Yang KY, Yi JL, Zhu XD, Ma J. The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun (Lond). 2021;41(11):1195\u20131227. https:\/\/doi.org\/10.1002\/cac2.12218. Epub 2021 Oct 26. PMID: 34699681; PMCID: PMC8626602.","DOI":"10.1002\/cac2.12218"},{"issue":"1","key":"13665_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12874-020-00945-9.PMID:32169052;PMCID:PMC7071747","volume":"20","author":"CM Sitlani","year":"2020","unstructured":"Sitlani CM, Lumley T, McKnight B, Rice KM, Olson NC, Doyle MF, Huber SA, Tracy RP, Psaty BM, Delaney JAC. Incorporating sampling weights into robust estimation of Cox proportional hazards regression model, with illustration in the Multi-Ethnic Study of Atherosclerosis. BMC Med Res Methodol. 2020;20(1):62. https:\/\/doi.org\/10.1186\/s12874-020-00945-9.PMID:32169052;PMCID:PMC7071747.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"13665_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","volume":"80","author":"SZ Lai","year":"2011","unstructured":"Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ, Ma J. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2011;80(3):661\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.03.024. (Epub 2010 Jul 17 PMID: 20643517).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"13665_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MOO.0b013e3280148a06","volume":"15","author":"WI Wei","year":"2007","unstructured":"Wei WI, Mok VW. The management of neck metastases in nasopharyngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2007;15(2):99\u2013102. https:\/\/doi.org\/10.1097\/MOO.0b013e3280148a06. (PMID: 17413410).","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"13665_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.radonc.2019.12.018","volume":"145","author":"WZ Li","year":"2020","unstructured":"Li WZ, Liu GY, Lin LF, Lv SH, Qiang MY, Lv X, Wu YS, Liang H, Ke LR, Wang DL, Yu YH, Qiu WZ, Liu KY, Guo X, Li JP, Zou YJ, Xiang YQ, Xia WX. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it. Radiother Oncol. 2020;145:101\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2019.12.018. (Epub 2020 Jan 10 PMID: 31931288).","journal-title":"Radiother Oncol"},{"issue":"1","key":"13665_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40880-019-0357-9.PMID:30925939;PMCID:PMC6441165","volume":"39","author":"SL Liu","year":"2019","unstructured":"Liu SL, Sun XS, Li XY, Tang LQ, Chen QY, Lin HX, Liang YJ, Yan JJ, Lin C, Guo SS, Liu LT, Li Y, Xie HJ, Tang QN, Liang H, Guo L, Mai HQ. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study. Cancer Commun (Lond). 2019;39(1):14. https:\/\/doi.org\/10.1186\/s40880-019-0357-9.PMID:30925939;PMCID:PMC6441165.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"13665_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13014-022-02147-7.PMID:36345003;PMCID:PMC9641821","volume":"17","author":"T Jin","year":"2022","unstructured":"Jin T, Liu NF, Jin QF, Hua YH, Chen XZ. Radiation dose escalation for locally advanced nasopharyngeal carcinoma patients with local and\/or regional residual lesions after standard chemoradiotherapy: a non-randomized, observational study. Radiat Oncol. 2022;17(1):176. https:\/\/doi.org\/10.1186\/s13014-022-02147-7.PMID:36345003;PMCID:PMC9641821.","journal-title":"Radiat Oncol"},{"key":"13665_CR14","doi-asserted-by":"publisher","unstructured":"Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheng ACK, Ng WT, Lee VHF, Ma BBY, Cheng HC, Wong FCS, Loong HHF, Tong M, Poon DMC, Ahuja AT, King AD, Wang K, Mo F, Zee BCY, Chan KCA, Lo YMD. Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial. J Clin Oncol. 2018: JCO2018777847. https:\/\/doi.org\/10.1200\/JCO.2018.77.7847. Epub ahead of print. PMID: 29989858.","DOI":"10.1200\/JCO.2018.77.7847"},{"issue":"9","key":"13665_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fonc.2019.00240.PMID:31024844;PMCID:PMC6460964","volume":"5","author":"L Zhao","year":"2019","unstructured":"Zhao L, Lin Q, Gu J, Zhang H, Chen H, Lin Q. A nomogram for the prediction of prognosis in patients with distant metastases of nasopharyngeal carcinoma. Front Oncol. 2019;5(9):240. https:\/\/doi.org\/10.3389\/fonc.2019.00240.PMID:31024844;PMCID:PMC6460964.","journal-title":"Front Oncol"},{"issue":"1","key":"13665_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12885-023-10641-8.PMID:36803318;PMCID:PMC9938628","volume":"23","author":"Z Fei","year":"2023","unstructured":"Fei Z, Hong H, Xu T, Xu Y, Chen J, Qiu X, Ding J, Feng Y, Huang C, Li L, Li M, Chen C. Analysis of risk characteristics for metachronous metastasis in different period of nasopharyngeal carcinoma. BMC Cancer. 2023;23(1):165. https:\/\/doi.org\/10.1186\/s12885-023-10641-8.PMID:36803318;PMCID:PMC9938628.","journal-title":"BMC Cancer"},{"key":"13665_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.oraloncology.2016.11.008","volume":"64","author":"YC Liu","year":"2017","unstructured":"Liu YC, Wang WY, Twu CW, Jiang RS, Liang KL, Wu CT, Lin PJ, Huang JW, Hsieh HY, Lin JC. Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients. Oral Oncol. 2017;64:15\u201321. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.11.008. (Epub 2016 Nov 30 PMID: 28024719).","journal-title":"Oral Oncol"},{"issue":"7","key":"13665_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s11547-023-01650-5","volume":"128","author":"X Teng","year":"2023","unstructured":"Teng X, Zhang J, Han X, Sun J, Lam SK, Ai QH, Ma Z, Lee FK, Au KH, Yip CW, Chow JCH, Lee VH, Cai J. Explainable machine learning via intra-tumoral radiomics feature mapping for patient stratification in adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Radiol Med. 2023;128(7):828\u201338. https:\/\/doi.org\/10.1007\/s11547-023-01650-5. (Epub 2023 Jun 10 PMID: 37300736).","journal-title":"Radiol Med"},{"key":"13665_CR19","doi-asserted-by":"publisher","unstructured":"Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16(4):1310\u20137. https:\/\/doi.org\/10.1200\/JCO.1998.16.4.1310. Corrected and republished in: J Clin Oncol. 2023;41(24):3965\u20133972. PMID: 9552031.","DOI":"10.1200\/JCO.1998.16.4.1310"},{"issue":"7","key":"13665_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S1470-2045(23)00232-2","volume":"24","author":"LT Liu","year":"2023","unstructured":"Liu LT, Liu H, Huang Y, Yang JH, Xie SY, Li YY, Guo SS, Qi B, Li XY, Chen DP, Jin F, Sun XS, Yang ZC, Liu SL, Luo DH, Li JB, Liu Q, Wang P, Guo L, Mo HY, Qiu F, Yang Q, Liang YJ, Jia GD, Wen DX, Yan JJ, Zhao C, Chen QY, Sun R, Tang LQ, Mai HQ. Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2\u20133 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2023;24(7):798\u2013810. https:\/\/doi.org\/10.1016\/S1470-2045(23)00232-2. (Epub 2023 Jun 5 PMID: 37290468).","journal-title":"Lancet Oncol"},{"issue":"1","key":"13665_CR21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41467-024-45276-1.PMID:38297016;PMCID:PMC10831082","volume":"15","author":"X Cao","year":"2024","unstructured":"Cao X, Huang HY, Liang CX, Lin ZC, Zhou JY, Chen X, Huang YY, Zhan ZJ, Ke LR, Han LJ, Xia WX, Tang LQ, Guo SS, Liang H, Guo X, Lv X. Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial. Nat Commun. 2024;15(1):949. https:\/\/doi.org\/10.1038\/s41467-024-45276-1.PMID:38297016;PMCID:PMC10831082.","journal-title":"Nat Commun"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13665-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:56:16Z","timestamp":1738947376000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13665-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13665"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13665-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. The study was approved by the Ethical Committee of Fujian Cancer Hospital (SQ2022\u2013169).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"All patients have read the Participant Information Sheet and Consent Form and consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}